They contain Noopept, a generous dose of vitamin C, and several other nootropic ingredients
GLP-1 therapies are moving beyond diabetes and obesity into MASH/NAFLD, cardiovascular risk reduction, and possibly neurodegenerative conditions
Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: A randomized placebo-controlled-phase 3 study
GLP-1 agonist signaling
A new target trial emulation analyzed insurance claims data from over 3,500 pregnancies and found that continuation of GLP-1 RAs during the first trimester of pregnancy was not associated with a substantially increased risk for pregnancy loss, abnormal fetal growth, or major birth defects
Skin, Gut, and Systemic Applications GLOW peptide therapy is commonly associated with: Skin rejuvenation and improved texture Collagen density and hydration support Post-procedure recovery Aesthetic-focused regenerative protocols KLOW peptide therapy is more often associated with: Gut issues such as leaky gut or immune imbalance Inflammatory skin conditions Systemic inflammation and metabolic stress Deep tissue repair requiring immune modulation KLOW helps maintain skin integrity during times of stress, travel, or illness by reducing inflammation that would otherwise impair healing